Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
FBRX compared with NERV: revenue, margins and what each company keeps, and the suppliers and customers both name
FBRX
Forte Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
NERV
Minerva Neurosciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
FBRX
Forte Biosciences, Inc.
vs
NERV
Minerva Neurosciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
FBRX: latest quarter not drawable. NERV: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only FBRX
0
None
Shared
0
No disclosed counterparties: FBRX.
Only NERV
7
RPRX
Royalty Pharma plc ("Royalty Pharma")
customer
—
Catalent
unlisted
supplier
—
Catalent Germany Schorndorf GmbH
unlisted
supplier
—
Dr. Inderjit Kaul
unlisted
supplier
3 more · NERV chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
FBRX
Forte Biosciences, Inc.
Change
76.99
▲
+0.03%
· post 77.01
· delayed
Mkt cap
$1.6B
NERV
Minerva Neurosciences, Inc.
Change
2.34
▲
+0.69%
· post 2.35
· delayed
After hours
Nov 2 '26
delayed
Mkt cap
$112.0M
vs
Compare
After hours
Nov 2 '26
delayed
FBRX
Forte Biosciences, Inc.
vs
NERV
Minerva Neurosciences, Inc.
76.99
▲
+0.03%
post 77.01
delayed
Price
2.34
▲
+0.69%
post 2.35
delayed
$1.6B
Mkt cap
$112.0M
Change
Change
FBRX
76.99
▲
+0.03%
vs
NERV
2.34
▲
+0.69%
After hours
Nov 2 '26
delayed
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
FBRX, solid
NERV, dashed